Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes

Clinica Chimica Acta

Volumn 430, Issue , 2014, Pages 134-139

  Idei, Mayumi ^a   Hirayama, Satoshi ^a   Miyake, Noriko ^a   Kon, Mika ^a   Horiuchi, Yuki ^a   Ueno, Tsuyoshi ^a   Miyake, Kazunori ^a   Satoh, Naotake ^b   Yoshii, Hidenori ^b   Yamashiro, Keiko ^b   Onuma, Tomio ^b   Miida, Takashi ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

Author keywords

Carotid atherosclerosis; Diabetic dyslipidemia; Postprandial hypertriglyceridemia

Indexed keywords

TRIACYLGLYCEROL;

BLOOD; CAROTID ARTERY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; REGRESSION ANALYSIS; RISK FACTOR;

CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTPRANDIAL PERIOD; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 84893514120     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.12.022     Document Type: Article

References (30)

1. Iso H., Naito Y., Sato S., et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 2001, 153:490-499.
2. Nordestgaard B.G., Benn M., Schnohr P., et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007, 298:299-308.
3. Bansal S., Buring J.E., Rifai N., et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007, 298:309-316.
4. Mora S., Rifai N., Buring J.E., et al. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008, 118:993-1001.
5. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 1979, 60:473-485.
6. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999, 246:341-355.
7. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001, 154:229-236.
8. National Cholesterol Education Program (NCEP) Expert Panel on Detection Ea, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
9. Cohn J.S., McNamara J.R., Cohn S.D., et al. Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 1988, 29:925-936.
10. Ai M., Tanaka A., Ogita K., et al. Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes. J Am Coll Cardiol 2001, 38:1628-1632.
11. O'Leary, DH Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
12. Jashari F., Ibrahimi P., Nicoll R., et al. Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis 2013, 227:193-200.
13. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2010, 1:2-20. 10.1007/s13340-010-0006-7.
14. Teramoto T., Sasaki J., Ueshima H., et al. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007, 14:155-158.
15. Kashiwagi A., Kasuga M., Araki E., et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012, 3:8-10. 10.1007/s13340-012-0069-8.
16. Terminology and Diagnostic Criteria Committee Japan Society of Ultrasonics in Medicine. Standard method for ultrasound evaluation of carotid artery lesions. Jpn J Med Ultrasonics 2009, 36:510-518. 10.1007/s10396-009-0238-y.
17. American Diabetes Association Standards of medical care in diabetes-2013. Daibetes Care 2013, 36(Suppl. 1):S11-66.
18. Collins R., Armitage J., Parish S., et al. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003, 361:2005-2016.
19. Colhoun H.M., Betteridge D.J., Durrington P.N., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentrerandomised placebo-controlled trial. Lancet 2004, 364:685-696.
20. Mazzone T., Chait A., Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 2008, 371:1800-1809.
21. Sone H., Tanaka S., Iimuro S., et al. Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study. Diabetes Care 2012, 35:1150-1157.
22. Keech A., Simes R.J., Barter P., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005, 366:1849-1861.
23. Ginsberg H.N., Elam M.B., Lovato L.C., et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010, 362:1563-1574.
24. Ginsberg H.N., Illingworth D.R. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol 2001, 88:9H-15H.
25. Taskinen M.R. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003, 46:733-749.
26. Austin M.A., Breslow J.L., Hennekens C.H., et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988, 260:1917-1921.
27. Hirayama S., Soda S., Ito Y., et al. Circadian change of serum concentration of small dense LDL-cholesterol in type 2 diabetic patients. Clin Chim Acta 2010, 411:253-257.
28. Bobik A. Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism. Circulation 2008, 118:702-704.
29. Kosuge K., Miida T., Takahashi A., et al. Estimating the fasting triglyceride concentration from the postprandial HDL-cholesterol and apolipoprotein CIII concentrations. Atherosclerosis 2006, 184:413-419.
30. Teno S., Uto Y., Nagashima H., et al. Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 2000, 23:1401-1406.